JointWell
Natural health product licensed in Canada
- Other names
- FlexWell, Joint Formula, Joint Support, Well-Joint
- Licence holder
- ApiWell Group Corp.
- NPN or DIN-HM
- 80082642
- Status
- Active licence
- Licence date
- 24 January 2018
- Revision date
- 9 June 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 400 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine sulfate | 500 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Sulfate de chondroïtine | 400 milligramme | Not calculated |
Non-medicinal ingredients
FD&C Yellow No. 5, Poly(éthylène glycol), Hydroxypropylcellulose, Stéarate de magnésium, des mono- et diglycérides d'acides gras, Cellulose microcristalline, Jaune soleil FCF, Talc, Saveur, Fast Green FCF (Green 3), Dioxyde de titane, Croscarmellose de sodium, Acide stéarique, Poly(alcool vinylique)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Helps to relieve (joint) pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner.
- Effets indésirables connus
Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
Source
Official Health Canada record, licence 80082642
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.